The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2020
Filed:
Feb. 23, 2016
Applicant:
Portland State University, Portland, OR (US);
Inventors:
Robert M. Strongin, Portland, OR (US);
Martha Sibrian-Vazquez, Portland, OR (US);
Jialu Wang, Portland, OR (US);
Jorge O. Escobedo-Cordova, Portland, OR (US);
Assignee:
Portland State University, Portland, OR (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 15/32 (2006.01); B01D 15/42 (2006.01); B01J 20/26 (2006.01); B01J 20/281 (2006.01); B01J 20/285 (2006.01); B01J 20/30 (2006.01); C08F 2/44 (2006.01); C08F 22/22 (2006.01); C12Q 1/02 (2006.01); G01N 1/40 (2006.01); G01N 33/545 (2006.01); G01N 33/92 (2006.01); G01N 30/00 (2006.01); G01N 30/06 (2006.01);
U.S. Cl.
CPC ...
B01J 20/268 (2013.01); B01D 15/325 (2013.01); B01D 15/426 (2013.01); B01J 20/281 (2013.01); B01J 20/285 (2013.01); B01J 20/3057 (2013.01); C08F 2/44 (2013.01); C08F 22/22 (2013.01); C12Q 1/02 (2013.01); G01N 1/405 (2013.01); G01N 33/545 (2013.01); G01N 33/92 (2013.01); B01J 2220/4812 (2013.01); B01J 2220/54 (2013.01); B01J 2220/62 (2013.01); G01N 2030/009 (2013.01); G01N 2030/062 (2013.01); G01N 2405/04 (2013.01); G01N 2600/00 (2013.01);
Abstract
Embodiments of templated polymeric materials capable of binding lysophosphatidic acids (LPAs) are disclosed. Methods of making and using the templated polymeric materials also are disclosed. The disclosed templated polymeric materials are molecularly imprinted polymers that bind LPAs and facilitate the production of lysophosphatidic acid-enriched samples, for instance through extraction of lysophosphatidic acids from biological samples, such as plasma or serum samples.